Company / Working Capital
Lilly (Eli) Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$20.4B
FY2025
5-year range
-$1.6B / $20.4B
FY2021-FY2025
Trend
+367.5%
vs FY2024
Sector context
#1 of 213
Health Care
What the data says
Working Capital changed +367% YoY in FY2025, a notable deviation from the 9-year average annual change of +61%.
Based on SEC 10-K filings.
$20.4B in FY2025 with a 5-year CAGR of +32.6%. Ranks 1st among 213 companies in Health Care.
Improved from -$1.6B to $20.4B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +183.4%
- 5-Year CAGR
- +32.6%
- 10-Year CAGR
- -
Sector benchmark
Top 0% in Health CareTop 0% of 213This company $20.4B Sector average $934.6M
▼
+2082.9% above sector average
Key checks
Key Insights
- 5-year CAGR of +32.6%, indicating consistent growth.
- In FY2025, working capital increased 367.5% year-over-year.
- Ranks #1 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.4B | +367.5% |
| FY2024 | $4.4B | +378.6% |
| FY2023 | -$1.6B | -274.7% |
| FY2022 | $896.3M | -73.6% |
| FY2021 | $3.4B | -31.7% |
| FY2020 | $5.0B | +157.5% |
| FY2019 | $1.9B | -77.7% |
| FY2018 | $8.7B | +85.6% |
| FY2017 | $4.7B | +13.4% |
| FY2016 | $4.1B | -5.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026